贵州三力：三力健康拟与创建永盛等有关方对参股公司药尊宝减资

Core Viewpoint - Guizhou Sanli (603439.SH) is restructuring its investment in the subsidiary Yaozunbao to optimize its business and asset structure, focusing on core operations [1] Summary by Relevant Sections Company Strategy - The company plans to reduce its investment in Yaozunbao by 20 million yuan, while its partner Chuangjian Yongsheng will reduce its investment by 12.4 million yuan [1] - After the capital reduction, Guizhou Sanli will no longer hold any equity in Yaozunbao, and Chuangjian Yongsheng's subscribed capital will change to 22.4 million yuan [1] Financial Impact - Yaozunbao currently has a registered capital of 80 million yuan, and the total capital reduction is 53.5975 million yuan, resulting in a new registered capital of 26.4025 million yuan [1] - Post-reduction, the shareholders of Yaozunbao will be Chuangjian Yongsheng and Chengdu Xinlan Internet Information Consulting Partnership (Limited Partnership), with all other shareholders exiting [1]